# Disc Medicine

Source: https://onco.cc/companies/disc-medicine/  
OnCo record `disc-medicine` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Disc Medicine is a US-based biotechnology company that leads 2 cancer trials in OnCo, testing DISC-0974 and DISC-3405 in myeloproliferative neoplasms and myelodysplastic syndromes / neoplasms.

## Summary

Disc Medicine is a clinical-stage biopharmaceutical company developing medicines for haematological diseases; its pipeline includes bitopertin, DISC-0974 and DISC-3405. On ClinicalTrials.gov it is the lead sponsor of 2 trials recorded in OnCo: NCT06985147 (phase 2, A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)) and NCT05320198 (phase 1/2, Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syn...). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Also known as: Disc Medicine, Inc
- Tags: ctgov-sponsor
- HQ: Watertown, Massachusetts
- Type: biotech
- Website: https://www.discmedicine.com/
- Ticker: NASDAQ:IRON

## Sources

- Official website: https://www.discmedicine.com/
- ClinicalTrials.gov: trials led by Disc Medicine: https://clinicaltrials.gov/search?lead=Disc%20Medicine%2C%20Inc

## Connected records

- cancers: [Myelodysplastic syndromes / neoplasms (MDS)](https://onco.cc/cancers/mds/), [Myeloproliferative neoplasms (PV, ET, myelofibrosis)](https://onco.cc/cancers/myeloproliferative-neoplasms/)
- trials: [A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)](https://onco.cc/trials/nct06985147/), [Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia](https://onco.cc/trials/nct05320198/)

---
JSON: https://onco.cc/api/v1/entities/disc-medicine.json